OrthoPediatrics Corp. Announces Distribution Agreement with MY01 Inc.
OrthoPediatrics (NASDAQ: KIDS) has announced a new distribution partnership with MY01 Inc. to expand access to MY01's Continuous Perfusion Sensing Technology (CPST) Platform for children and adolescents. The partnership focuses on addressing acute compartment syndrome, a time-sensitive emergency condition that particularly affects children with orthopedic traumatic injuries.
The collaboration combines MY01's innovative technology with OrthoPediatrics' dedicated pediatric sales force and medical education resources. This partnership aims to provide clinicians with better tools and training for diagnosing and treating compartment syndrome in pediatric patients, who often struggle to communicate symptoms effectively.
OrthoPediatrics (NASDAQ: KIDS) ha annunciato una nuova partnership distributiva con MY01 Inc. per ampliare l'accesso alla piattaforma di Continuous Perfusion Sensing Technology (CPST) di MY01 per bambini e adolescenti. L'accordo mira ad affrontare la sindrome compartimentale acuta, un'emergenza che richiede interventi tempestivi e che colpisce in particolare i giovani con traumi ortopedici.
La collaborazione unisce la tecnologia innovativa di MY01 alla rete di vendita pediatrica e alle risorse di formazione medica di OrthoPediatrics. L'obiettivo è fornire ai clinici strumenti e formazione migliori per diagnosticare e trattare la sindrome compartimentale nei pazienti pediatrici, che spesso hanno difficoltà a comunicare i sintomi.
OrthoPediatrics (NASDAQ: KIDS) ha anunciado una nueva alianza de distribución con MY01 Inc. para ampliar el acceso a la plataforma Continuous Perfusion Sensing Technology (CPST) de MY01 para niños y adolescentes. La asociación se centra en abordar el síndrome compartimental agudo, una emergencia que requiere atención rápida y que afecta especialmente a los menores con lesiones ortopédicas traumáticas.
La colaboración combina la tecnología innovadora de MY01 con la fuerza de ventas pediátrica y los recursos de educación médica de OrthoPediatrics. El propósito es ofrecer a los clínicos mejores herramientas y capacitación para diagnosticar y tratar el síndrome compartimental en pacientes pediátricos, quienes con frecuencia tienen dificultades para expresar sus síntomas.
OrthoPediatrics (NASDAQ: KIDS)는 소아·청소년을 위한 MY01의 Continuous Perfusion Sensing Technology(CPST) 플랫폼 접근성을 넓히기 위해 MY01 Inc.와 새로운 유통 파트너십을 발표했습니다. 이번 파트너십은 특히 정형외과 외상으로 인해 발생하는 소아의 시간민감 응급질환인 급성 구획증후군 대응에 중점을 둡니다.
이번 협력은 MY01의 혁신적 기술과 OrthoPediatrics의 소아 전문 영업망 및 의료 교육 자원을 결합합니다. 목표는 증상 표현이 어려운 소아 환자들을 위해 임상의가 구획증후군을 더 잘 진단하고 치료할 수 있도록 향상된 도구와 교육을 제공하는 것입니다.
OrthoPediatrics (NASDAQ: KIDS) a annoncé un nouveau partenariat de distribution avec MY01 Inc. pour étendre l'accès à la plateforme Continuous Perfusion Sensing Technology (CPST) de MY01 destinée aux enfants et aux adolescents. Le partenariat vise à traiter le syndrome des loges aigu, une urgence sensible au facteur temps qui touche particulièrement les enfants victimes de traumatismes orthopédiques.
Cette collaboration associe la technologie innovante de MY01 à la force de vente pédiatrique et aux ressources de formation médicale d'OrthoPediatrics. L'objectif est d'offrir aux cliniciens de meilleurs outils et une formation accrue pour diagnostiquer et traiter le syndrome des loges chez les patients pédiatriques, qui ont souvent du mal à exprimer leurs symptômes.
OrthoPediatrics (NASDAQ: KIDS) hat eine neue Distributionspartnerschaft mit MY01 Inc. angekündigt, um den Zugang zur Continuous Perfusion Sensing Technology (CPST)-Plattform von MY01 für Kinder und Jugendliche zu erweitern. Die Partnerschaft konzentriert sich auf die Behandlung des akuten Kompartmentsyndroms, einer zeitkritischen Notfallsituation, die besonders Kinder mit orthopädischen Traumata betrifft.
Die Zusammenarbeit verbindet MY01s innovative Technologie mit der auf Pädiatrie spezialisierten Vertriebsmannschaft und den medizinischen Schulungsressourcen von OrthoPediatrics. Ziel ist es, Klinikern bessere Werkzeuge und Fortbildungen zur Diagnose und Behandlung des Kompartmentsyndroms bei pädiatrischen Patienten bereitzustellen, die häufig Probleme haben, Symptome klar zu kommunizieren.
- Partnership expands access to innovative CPST Platform for pediatric patients
- Addresses critical medical need in pediatric trauma monitoring
- Leverages OrthoPediatrics' specialized sales force and education resources
- None.
Insights
OrthoPediatrics' partnership with MY01 expands access to critical compartment syndrome monitoring technology for pediatric patients, strengthening their trauma care portfolio.
This distribution agreement between OrthoPediatrics and MY01 represents a strategic expansion of OrthoPediatrics' trauma care capabilities. The partnership will integrate MY01's Continuous Perfusion Sensing Technology (CPST) Platform into OrthoPediatrics' pediatric-focused distribution network, addressing a critical clinical challenge in pediatric orthopedic trauma.
Acute compartment syndrome is a serious medical emergency that disproportionately affects children with certain orthopedic injuries including floating elbow, tibial, and forearm fractures. The condition occurs when pressure builds within muscle compartments, restricting blood flow and potentially leading to permanent tissue damage. What makes this partnership particularly valuable is that diagnosing compartment syndrome in children presents unique challenges – pediatric patients often cannot articulate pain levels clearly, and clinical signs may be subtle or easily missed.
MY01's technology provides continuous monitoring of compartment pressure, offering an objective measurement tool that complements clinical assessment. For OrthoPediatrics, this agreement enhances their specialized pediatric trauma portfolio without requiring the development costs of creating such technology internally. The company gains a differentiated offering that aligns perfectly with their exclusive focus on pediatric orthopedics.
The deal leverages OrthoPediatrics' established sales force and educational infrastructure while expanding MY01's reach into the pediatric market. This kind of specialized distribution partnership helps smaller medical technology companies like MY01 gain market penetration within specific patient populations without building dedicated sales teams. For clinicians treating pediatric trauma patients, having access to both the technology and specialized training through OrthoPediatrics' education programs could lead to earlier detection of compartment syndrome and potentially reduce the need for fasciotomies and other invasive interventions.
Advancing Care for Pediatric Trauma Patients
WARSAW, Ind., Sept. 05, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics announced today a new distribution partnership with MY01, an innovative medical technology company focused on transforming the diagnosis of limb perfusion injuries. This collaboration will expand access to MY01’s Continuous Perfusion Sensing Technology™ (CPST™) Platform for children and adolescents, a population at great risk for acute compartment syndrome.
Acute compartment syndrome is a time-sensitive emergency that disproportionately affects children with a floating elbow1, tibial2 and forearm3 fractures, and other orthopedic traumatic injuries4. Diagnosing acute compartment syndrome in pediatric patients can be challenging: children may struggle to verbalize pain, and early warning signs are often subtle.
“This partnership isn’t just about scale, it’s about impact,” commented Andrew Morris, Chief Commercial Officer at MY01. “Children represent the group most at-risk for compartment syndrome, and with OrthoPediatrics we can ensure clinicians have access to the right tools, at the right time, to avoid unnecessary surgeries and life-altering complications such as limb loss for these patients."
“At OrthoPediatrics, we’ve always been driven by one goal: to help children whose lives have been impacted by orthopedic conditions,” said Fady Rayes, Vice-President of Product Development. “Partnering with MY01 extends that mission into trauma monitoring, pairing innovative technology with our focus on education and surgeon support.”
By combining MY01’s CPST Platform with OrthoPediatrics’ dedicated pediatric sales force and commitment to medical education, clinicians will gain the tools and training needed to reduce variability in care, ensuring optimized outcomes for all pediatric patients.
About MY01
Founded in 2019 and based in Montreal, MY01 envisions a world where every disease is quantifiable, allowing for precise, personalized care for all patients. Our Continuous Perfusion Sensing Technology (CPST) Platform has the potential to transform trauma programs by translating complex biological signs into dynamic, actionable, real-time data that supports better decision-making. This reduces variations in care and delivers improved outcomes, enabling hospitals to allocate resources as efficiently as possible. MY01 is currently operational in the USA, Europe, and Canada, setting new standards in healthcare.
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 80 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com.
1 Blakemore, L. C., Cooperman, D. R., Thompson, G. H., Wathey, C., & Ballock, R. T. (2000). Compartment syndrome in ipsilateral humerus and forearm fractures in children. Clin Orthop Relat Res(376), 32-38. https://doi.org/10.1097/00003086-200007000-00006
2 Obey, M. R., Shlykov, M. A., Nickel, K. B., Keller, M., & Hosseinzadeh, P. (2023). Incidence and risk factors for acute compartment syndrome in pediatric tibia fractures. J Pediatr Orthop B, 32(4), 401-404. https://doi.org/10.1097/bpb.0000000000000985
3 Grottkau, B. E., Epps, H. R., & Di Scala, C. (2005). Compartment syndrome in children and adolescents. J Pediatr Surg, 40(4), 678-682. https://doi.org/10.1016/j.jpedsurg.2004.12.007
4 Bae, D. S., Kadiyala, R. K., & Waters, P. M. (2001). Acute Compartment Syndrome in Children: Contemporary Diagnosis, Treatment, and Outcome. Journal of Pediatric Orthopaedics, 21(5), 680-688.
Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406
FAQ
What is the new partnership between OrthoPediatrics (NASDAQ: KIDS) and MY01?
How will the MY01 partnership benefit pediatric patients?
What is the significance of CPST Platform for pediatric orthopedics?
How will OrthoPediatrics implement MY01's technology?
